Nacario, Daniella T.

HRN: 27-35-95  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2025
CEFTRIAXONE 1G (VIAL)
06/23/2025
06/30/2025
IV
1.9 G
Q 12
T/C Brain Abscess
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Central Nervous System    Compliance to guidelines: